Ilari Mäki-Opas
0000-0003-0918-040X
Tampere University
4 papers found
Refreshing results…
TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in bleomycin-induced experimental model of scleroderma
TRPA1 Mediates Contact Hypersensitivity Induced by 2,4-Dinitrochlorobenzene
Pyrazine-Fused Triterpenoids Block the TRPA1 Ion Channel in Vitro and Inhibit TRPA1-Mediated Acute Inflammation in Vivo
Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner
Missing publications? Search for publications with a matching author name.